Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

DR Wang, XL Wu, YL Sun - Signal transduction and targeted therapy, 2022 - nature.com
Cancers are highly complex diseases that are characterized by not only the overgrowth of
malignant cells but also an altered immune response. The inhibition and reprogramming of …

Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy

L Cai, Y Li, J Tan, L Xu, Y Li - Journal of hematology & oncology, 2023 - Springer
In one decade, immunotherapy based on immune checkpoint blockades (ICBs) has become
a new pillar of cancer treatment following surgery, radiation, chemotherapy, and targeted …

Research progress on dendritic cell vaccines in cancer immunotherapy

J Yu, H Sun, W Cao, Y Song, Z Jiang - Experimental hematology & …, 2022 - Springer
Dendritic cell (DC) vaccines induce specific immune responses that can selectively
eliminate target cells. In recent years, many studies have been conducted to explore DC …

[HTML][HTML] Immune-related adverse events of immune checkpoint inhibitors: a review

Q Yin, L Wu, L Han, X Zheng, R Tong, L Li… - Frontiers in …, 2023 - frontiersin.org
Since the first Immune Checkpoint Inhibitor was developed, tumor immunotherapy has
entered a new era, and the response rate and survival rate of many cancers have also been …

Review of the immune checkpoint inhibitors in the context of cancer treatment

NA Alturki - Journal of Clinical Medicine, 2023 - mdpi.com
Checkpoint proteins are an integral part of the immune system and are used by the tumor
cells to evade immune response, which helps them grow uncontrollably. By blocking these …

The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer

JJ Li, JH Wang, T Tian, J Liu, YQ Zheng, HY Mo… - Nature …, 2023 - nature.com
Colorectal cancer (CRC) patients with liver metastases usually obtain less benefit from
immunotherapy, and the underlying mechanisms remain understudied. Here, we identify …

Expression of human endogenous retrovirus group K (HERV-K) HML-2 correlates with immune activation of macrophages and type I interferon response

E Russ, N Mikhalkevich, S Iordanskiy - Microbiology Spectrum, 2023 - Am Soc Microbiol
Human endogenous retroviruses (HERVs) comprise about 8.3% of the human genome and
are capable of producing RNA molecules that can be sensed by pattern recognition …

Immunomodulatory properties of immune checkpoint inhibitors—more than boosting T-cell responses?

M Kuske, M Haist, T Jung, S Grabbe, M Bros - Cancers, 2022 - mdpi.com
Simple Summary Tumor immune evasion is mediated in large part by the inhibition of anti-
tumor T cell responses. Both the induction of tumor antigen-specific T cells and the activation …

Fibrinogen-like protein 1 promotes liver-resident memory T-cell exhaustion in hepatocellular carcinoma

C Yang, Q Qian, Y Zhao, B Huang, R Chen… - Frontiers in …, 2023 - frontiersin.org
Background and aims The key role of tissue-resident memory T (TRM) cells in the immune
regulation of hepatocellular carcinoma (HCC) has been investigated and reported, but the …

Xue-Jie-San restricts ferroptosis in Crohn's disease via inhibiting FGL1/NF-κB/STAT3 positive feedback loop

Y Gao, Z Zhang, J Du, X Yang, X Wang… - Frontiers in …, 2023 - frontiersin.org
Crohn's disease (CD) is an incurable inflammatory bowel disease due to unclear etiology
and pathogenesis. Accumulating evidences have shown the harmful role of ferroptosis in …